Taoping Shi

Chinese PLA General Hospital, Hainan 301 Hospital

Papers

9

Total Citations

298

H-Index

8

About

Dr. Taoping Shi is a pioneering urological surgeon whose research is reshaping the landscape of robotic surgery, with a particular focus on complex oncologic procedures and the emerging frontier of telesurgery. His most impactful work centers on the management of advanced renal cell carcinoma, where he has developed and refined robot-assisted techniques for inferior vena cava (IVC) thrombectomy. His landmark 2019 paper on robot-assisted Level III-IV IVC thrombectomy, cited 99 times, established a step-by-step protocol for this challenging procedure, while his subsequent multi-institutional analysis provided a critical decision-making scheme for Level II thrombi. Dr. Shi has also made significant contributions to the optimization of robotic partial nephrectomy, including the innovative “Garland” technique for hilar tumors, and has conducted meta-analyses comparing surgical approaches for kidney cancer. Notably, he is a leading figure in the validation of telesurgery, demonstrating through a 2023 series and a 2024 preclinical experiment the safety and reliability of remote robotic operations, culminating in a 2026 multicentre randomised controlled trial that confirmed the non-inferiority of urological telesurgery. With over 300 total citations, Dr. Shi’s work is not only advancing surgical precision but also breaking down geographic barriers to specialized care.

Research Focus

Key Achievements

8
H-Index
9
Papers
298
Total Citations
33
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted Level III-IV Inferior Vena Cava Thrombectomy: Initial Series with Step-by-step Procedures and 1-yr Outcomes
99 citations · 2019
📈 Most Prolific Year: 2020 (3 Papers)
🤝 Key Collaborators: 95
🏛 Institutions: Chinese PLA General Hospital, Hainan 301 Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago